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transverse preoperative series and, respectively, 12 and 15 
postoperative scans. The median P95 was 1.2 mm or smaller, 
for all orientations (table 1). High values up to 6.6 mm were 
found in only three patients during short, deep aspiration. 
Regular breathing was observed in the other scans. No 
differences were found between pre- and post-BCS situations 
(p > 0.05).  
 
 
Conclusions: Intra-fraction breast and CTV motion is limited, 
before and after BCS, in supine RT position. This is essential 
for safe delivery of new hypofractionated RT treatments. 
Further research is planned to analyse intrafraction motion 
on a longer time scale. 
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Purpose/Objective: Several approaches are used in clinical 
practice for the management of prostate intra-fraction (i-f) 
motion. They range from using historically based standard 
PTV margins to the use of population margin recipes based on 
determined or published errors. We investigated the 
effectiveness of such methods based on a large study of all 
treatment fractions for 100 prostate patients undergoing 
radiotherapy at our institution. 
Materials and Methods: Pre and post-treatment kV 
orthogonal images were collected for a total of 3559 
treatment fractions. From this dataset we determined and 
characterised i-f motion and evaluated the effectiveness of 
the differing margin approaches to account for all patients 
within the study group. Strategies for the effective 
management of all patients within the study population were 
formulated.  
Results: The mean (StdDev) i-f motion from all observations 
is -0.07 (0.21), 0.07 (0.20), -0.01 (0.16) cm for the AP, SI and 
LR directions respectively. A derived population margin to 
cover 90% of patients with 95% dose is 0.52, 0.50, 0.42 cm for 
AP, SI, LR respectively. Extending the margin to cover 99% of 
patients with 95% dose requires a further increase of 0.15 cm 
which is similar to our institutional isotropic margin of 0.7 
cm.  
Six patients from our study group had i–f displacements > 
0.52 cm for >10% of treatment fractions. The mean (StdDev) 
for this subgroup is -0.33 (0.24), 0.22 (0.21), 0.05 (0.19) cm 
in the AP, SI and LR directions respectively. The subgroup has 
a significant i-f posterior-inferior displacement compared to 
the whole study group (p<0.001) resulting in a 3D 
displacement > 0.70 cm for 19% of observations and >0.52 cm 
for 37% of observations. Imaging for i-f motion for the first 5 
fractions is able to identify all 6 problem patients with a 
sensitivity = 1 and specificity = 0.84 (90% confidence level, 
0.12 cm confidence interval) whereas imaging the first 3 
fractions has a sensitivity and specificity of 0.67 and 0.84. 
The challenge posed by the subgroup is shown (fig) by the 
increased margin to achieve the same percentage cover.  
 
 
 
Conclusions: We have identified a subgroup of patients that 
display a significant post-inf directional displacement during 
treatment that is inadequately managed by an isotropic 
margin approach. Ideally these would be identified early in 
the treatment course to allow for proactive management. In 
considering a management strategy to afford optimal margins 
without compromising cover; whilst imaging for the first few 
fractions is clearly shown to be of benefit, our findings 
support the argument for real time tracking in prostate 
radiotherapy especially where posterior PTV margin reduction 
is used as a strategy for improving rectal sparing.  
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Purpose/Objective: Intra-fraction motion of the prostate can 
be a limiting factor to the quality of delivery of external 
beam radiotherapy. According to the 'random walk' 
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hypothesis, the intra-fraction positions of the prostate are 
not independently distributed. Rather, the prostate follows a 
continuous path where each position is strongly correlated to 
its previous position. In this study, the random walk 
hypothesis was prospectively tested, parameters of the 
motion were determined, and implications for intra-fraction 
motion management were explored. 
Materials and Methods: 70,573 prostate positions were 
tracked by 4D perineal ultrasound (Elekta Clarity) during 84 
fractions of external beam radiotherapy in 6 patients. 
Maximum likelihood model parameters were fitted to the 
data. The null hypothesis of a random walk was tested by the 
Dickey-Fuller test. The null hypothesis of stationarity was 
tested by the Kwiatkowski-Phillips-Schmidt-Shin test. The 
increase of variance in prostate position over time and the 
variability in motility between fractions and patients were 
analyzed. 
Results: Intra-fraction motion of the prostate was best 
described as a stochastic process with an auto-correlation 
coefficient of ρ=0.92±0.13. The random walk hypothesis 
(ρ=1) could not be rejected (p=0.27). The static noise 
hypothesis (ρ=0) was rejected (p<0.001). The Dickey-Fuller 
test rejected the null hypothesis ρ=1 in 25% to 32% of cases. 
On average, the Kwiatkowski-Phillips-Schmidt-Shin test 
rejected the null hypothesis ρ=0 with a probability of 93% to 
96%. The variance in prostate position increased linearly over 
time (r² = 0.9±0.1). There was substantial variability in 
motility between fractions and patients with maximum 
aberrations from isocenter ranging from 0.5 mm to over 10 
mm per fraction in one patient alone. 
Conclusions: Evidence strongly suggests that intra-fraction 
motion of the prostate is a random walk and neither static 
(like inter-fraction setup errors) nor stationary (like a cyclic 
motion such as breathing, for example). The prostate tends 
to drift away from the isocenter during a fraction, and this 
variance increases with time, such that shorter fractions are 
beneficial to the problem of intra-fraction motion. Also, 
there is high variability in the motility between fractions and 
patients. As a consequence, fixed safety margins (which 
would over-compensate at the beginning and under-
compensate at the end of a fraction) cannot optimally 
account for intra-fraction motion. Instead, online tracking 
and position correction on-the-fly should be considered as 
the preferred approach to control intra-fraction motion. 
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Purpose/Objective: The aim of this study was to obtain the 
PTV margin for IMRT prostate patients who were treated 
using an IGRT system (EXAC-TRAC ® - Brainlab). The second 
objective was to assess the margin of the pelvic nodes since 
our protocol consists of a daily correction based on 4 fiducial 
markers (gold seeds) implanted in the prostate. 
Materials and Methods: Twenty four patients were imaged 
and 1177 pairs of stereoscopic images were used in this 
study. 17 of these 24 patients were implanted four gold seeds 
in the prostate and were enrolled in our daily protocol: 
1º) bone registration 
2º) implanted markers registration before treatment 
3º) IMRT treatment 
4º) implanted markers registration just after treatment 
delivery to assess the intrafraction motion of the prostate 
and patient jointly. 
The remaining 7 patients without implanted seeds followed a 
different protocol using only bone registration before and 
just after treatment, which allowed us to assess the 
intrafraction motion of the patient (not the prostate). 
We used the following formula to calculate the margin of the 
PTV: 
margin CTV - PTV = 2.5∑ + β (σ - σp)  
where Σ represents the standard deviation from the 
combined systematic Gaussian errors, σ represents the 
standard deviation from the combined treatment execution 
errors, σp represents the unblurred beam penumbra width 
and β is a correction factor which depends on the field 
arrangement (7 fields equally-spaced in our protocol). 
To calculate ∑ and σ we included the setup, motion and 
intrafraction motion uncertainties, distinguishing in this case 
between prostate and patient intrafraction motion and 
patient only intrafraction motion. 
Results: If no correction were made the PTV (prostate only) 
margin would be 5.3 mm, 9.9 mm and 10.5 mm in lateral, 
longitudinal and vertical directions respectively (taking into 
account setup, motion and prostate+patient intrafraction 
motion uncertainties). However, following our protocol 
(implanted markers daily correction), the PTV (prostate) 
margin is 3.1 mm, 3.4 mm and 4.9 mm in lateral, longitudinal 
and vertical directions, and these values only depend on the 
prostate+patient intrafraction motion (PTV delineation 
uncertainty has not been taken into account). 
Since we use implanted markers registration, the margin of 
the pelvic nodes is greater than the previous margin. In order 
to calculate the margin of the pelvic nodes, we have included 
the relative motion between bone and fiducials and the 
intrafraction motion of the patient only (not the prostate) 
uncertainties. Therefore the margin for pelvic nodes is 2.4 
mm, 7.7 mm and 6.3 mm in lateral, longitudinal and vertical 
directions. 
Conclusions: Our protocol allows us to reduce considerably 
the PTV margin in the prostate. However the significant 
motion observed between markers and bone in several 
patients forces us to keep a high pelvic nodes margin. On the 
other hand, it is important to distinguish between 
prostate+patient intrafraction motion and patient motion and 
use the latter to calculate the pelvic nodes margin. 
Otherwise, this margin would be overestimated.  
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Purpose/Objective: Respiratory tumor motion increases the 
target volume. Real time tumor tracking allows reduction of 
